Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 0 | 0 | 0 | 145 | 1,918 |
Gross Profit | N/A | N/A | N/A | 145 | 1,918 |
Operating Expenses | 14,579 | 16,600 | 14,281 | 11,862 | 9,308 |
Operating Income | -14,579 | -16,600 | -14,281 | -11,717 | -7,390 |
Other Income | 1,594 | 122 | -53 | -9 | 51 |
Pre-tax Income | -12,985 | -16,478 | -14,334 | -11,726 | -7,339 |
Net Income Continuous | -12,985 | -16,478 | -14,334 | -11,726 | -7,339 |
Net Income | $-12,985 | $-16,478 | $-14,334 | $-11,726 | $-7,339 |
EPS Basic Total Ops | -2.89 | -4.85 | -2.79 | -2.34 | -1.35 |
EPS Basic Continuous Ops | -2.45 | -3.16 | -2.79 | -2.34 | -1.39 |
EPS Diluted Total Ops | -2.89 | -4.85 | -2.79 | -2.34 | -1.35 |
EPS Diluted Continuous Ops | -2.45 | -3.16 | -2.79 | -2.34 | -1.39 |
EBITDA(a) | $-14,554 | $-16,505 | $-14,207 | $-11,645 | $-7,318 |